SCHEMBL23974249

SCHEMBL23974249

Cc1cc(NC=O)ccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 1/20 0.43
CDK4 P11802 1/20 0.43
CCND1 P24385 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
ALDH1A1 P00352 2/20 0.38
RAPGEF4 Q8WZA2 1/20 0.37
KIF11 P52732 2/20 0.36
KDR P35968 5/20 0.36
FLT1 P17948 4/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
DAO P14920 1/20 0.36
TAS2R14 Q9NYV8 1/20 0.36
NPC1 O15118 2/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.34
KMT2A Q03164 2/20 0.34
FFAR4 Q5NUL3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17805401 0.87 TAS2R14 (0.48) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL19287089 0.79 KIF11 (0.50) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL23974730 0.79 CCNE2 (0.41) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL30750830 0.79 RAPGEF4 (0.40) RAPGEF4KIF11KDRFLT1LMNA
SCHEMBL6535264 0.79 AR (0.46) RAPGEF4KIF11KDRFLT1LMNA
SCHEMBL5543216 0.78 MAPT (0.49) ALDH1A1LMNAHTTSMN1; SMN2NPC1
SCHEMBL30555452 0.78 MAPT (0.49) ALDH1A1LMNAHTTSMN1; SMN2NPC1
SCHEMBL23974261 0.78 NOTUM (0.46) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL6898031 0.78 SLC22A12 (0.49) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL29886395 0.78 NOTUM (0.46) CCNE2CDK4CCND1CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021219090-A1 QUINOXALINE DIONE DERIVATIVE AS IRREVERSIBLE INHIBITOR OF KRAS G12C MUTANT PROTEIN 北京泰德制药股份有限公司 (CN) 2021-11-04 WO disclosed